Management option for early tage of acutely ymptomatic macular hole

PURPOE: To evaluate management option for acutely ymptomatic tage I macular hole, and vitrectomy with intraocular ga tamponade for advanced tage I macular hole. METHOD: Retropective noncomparative tudy. etting: Clinical practice. tudy population: Acutely ymptomatic tage I macular hole. Management option: (I) pontaneou reolution with obervation −7 eye; (II) tage I hole developing poor viual acuity of 20/50 or wore during obervation −9 eye undergoing par plana vitrectomy, poterior vitreou eparation, fluid −20% ulfur hexafluoride ga exchange; (III) tage I hole acutely progreing to tage II or III during obervation −9 eye with vitrectomy, poterior vitreou eparation, membrane peel, fluid −18% perfluoropropane ga exchange. Main Outcome Meaure: viual acuity of 20/40 of better, prevention, or cloure of macular hole. REULT: pontaneou reolution developed in 7 eye with 20/40 or better viion (group I). 8/9 eye undergoing vitrectomy for advanced tage I hole (group II) did not progre and recovered 20/40 or better viion. 1/9 recovered 20/40 viion after further urgery. 9/9 eye following acute progreion to full-thickne hole (group III) had cloed macular hole with recovery of 20/40 viion after vitrectomy. CONCLUION: tage I macular hole can initially be oberved. However, excellent viual and urgical reult can be obtained in tage I hole with poor viion, or with acute progreion to full-thickne hole